Advertisement

Ancillary Course Info

The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice. It is recommended that attendees have already completed preparatory coursework (eg Foundations of Lipidology [formerly Lipid Academy] or similar core curriculum training).

This course is particularly useful to explore the details of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

Masters in Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Course Curriculum:

Lipoprotein Metabolism, Genetics, and Familial Lipid Disorders
Advanced Lipidology: Cardiovascular Biomarkers and Atherosclerosis Imaging
Obesity, Metabolic Syndrome and Diabetes Mellitus
Evidence-Based Nutrition and Lifestyle Modifications
Pharmacology Part I- Lipid Altering Drugs
Pharmacology Part II- Evidence Based Therapy
Complex Case and Consultative Lipidology 

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with expertise in Lipidology looking for further advanced training.


To register for the next Masters in Lipidology Course in Nashville, Tennessee, September 20-21, 2018, click here:

 

The National Lipid Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 14 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.

CE Credit provided by The National Lipid Association
Pharmacists
Universal Activity Number - JA0007192-0000-18-003-L01-P (Application)
This activity has been approved for 14.75 contact hours (1.475 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 14.7.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/ claimed credit form at www.lipid.org/cme.

For Pharmacists:
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support
Full notification of commercial support will be provided in the activity syllabus.

Harold E. Bays, MD, FTOS, FACC, FACE, FNLA

Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY
Diplomate, American Board of Clinical Lipidology
Alan S. Brown, MD, FNLA

President, National Lipid Association
Director, Division of Cardiology
Advocate Lutheran General Hospital
Co-Director, Cardiology Service Line
Advocate Medical Group
Clinical Associate Professor, Loyola Stritch School of Medicine
Park Ridge, IL
Diplomate, American Board of Clinical Lipidology
Anne C. Goldberg, MD, FACP, FNLA

President, Foundation of the NLA
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Terry A. Jacobson, MD, FACP, FAHA, FNLA

Professor of Medicine Director
Office of Health Promotion and Disease Prevention
Emory University
Atlanta, GA
Diplomate, American Board of Clinical Lipidology
Kevin C. Maki, PhD, FNLA, CLS

Chief Scientist
MB Clinical Research
Glen Ellyn and Chicago, IL
Boca Raton, FL
Diplomate, Accreditation Council for Clinical Lipidology
Carl E. Orringer, MD, FACC, FNLA

Associate Professor of Medicine
University of Miami
School of Medicine
Miami, FL
Diplomate, American Board of Clinical Lipidology

2018 Masters in Lipidology at the Fall Clinical Lipid Update- Nashville

Thursday, September 20, 2018

Day 1

7:00 - 7:30 AM Registration & Breakfast

Add

7:30 - 7:40 AM Program Overview Harold E. Bays, MD, FNLA
7:40 - 9:40 AM Pharmacology – Lipid Altering Drugs Harold E. Bays, MD, FNLA
9:40 - 10:00 AM Coffee Break
10:00 - 11:40 AM Advanced Lipidology: Cardiovascular Biomarkers and Atherosclerosis Imaging Kevin C. Maki, PhD, CLS, FNLA
11:40 - 12:15 Be the Master – Critical Journal Review Harold E. Bays, MD, FNLA
12:15 - 12:50 Lunch
12:50 - 2:30 PM Evidence-Based Nutrition and Lifestyle Modifications Anne C. Goldberg, MD, FNLA
2:30 - 2:40 PM Break
2:40 - 3:40 PM Diabetes Mellitus, Metabolic Syndrome, and Obesity Harold E. Bays, MD, FNLA
3:40 - 3:50 PM Break
3:50 - 5:40 PM Advanced Lipoprotein Metabolism and Genetic Disorders Alan S. Brown, MD, FNLA

Add

Friday, September 21, 2018

Day 2

7:00 - 7:30 AM Breakfast

Add

7:30 - 7:35 AM Day Overview Terry A. Jacobson, MD, FNLA
7:35 - 9:25 AM Consultative Lipidology and Specific Populations Carl E. Orringer, MD, FNLA
9:25 - 9:45 AM Coffee Break
9:45 - 11:35 AM Pharmacology - Evidence Based Therapy Terry A. Jacobson, MD, FNLA
11:35 - 12:15 Lunch
12:15 - 2:05 PM Advanced Complex Cases Terry A. Jacobson, MD, FNLA
2:05 - 2:20 PM Course Wrap-up Terry A. Jacobson, MD, FNLA

Add

Add

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service